SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-23-081597
Filing Date
2023-10-30
Accepted
2023-10-30 17:24:09
Documents
58
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0623a1_adialpharma.htm   iXBRL 10-Q/A 588517
2 CERTIFICATION f10q0623a1ex31-1_adialpharma.htm EX-31.1 12180
3 CERTIFICATION f10q0623a1ex31-2_adialpharma.htm EX-31.2 12222
4 CERTIFICATION f10q0623a1ex32-1_adialpharma.htm EX-32.1 5517
5 CERTIFICATION f10q0623a1ex32-2_adialpharma.htm EX-32.2 5225
  Complete submission text file 0001213900-23-081597.txt   4143152

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20230630.xsd EX-101.SCH 48973
7 XBRL CALCULATION FILE adil-20230630_cal.xml EX-101.CAL 35242
8 XBRL DEFINITION FILE adil-20230630_def.xml EX-101.DEF 219308
9 XBRL LABEL FILE adil-20230630_lab.xml EX-101.LAB 451050
10 XBRL PRESENTATION FILE adil-20230630_pre.xml EX-101.PRE 231595
51 EXTRACTED XBRL INSTANCE DOCUMENT f10q0623a1_adialpharma_htm.xml XML 413826
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-38323 | Film No.: 231361573
SIC: 2834 Pharmaceutical Preparations